Works matching IS 11100362 AND DT 2023 AND VI 34 AND IP 1

Combination of chemotherapeutic agents and biological response modifiers (immunotherapy) in triple-negative/Her2( +) breast cancer, multiple myeloma, and non-small-cell lung cancer.

Published in:

Journal of the Egyptian National Cancer Institute, 2023, v. 34, n. 1, p. 1, doi. 10.1186/s43046-022-00159-8

By:

• Morse, William;
• Nawaz, Haroon;
• Choudhry, Ayesha A.

Publication type:

Article